Meissner S, Schwenke H, Witzel E, Achenbach H
Z Urol Nephrol. 1986 Apr;79(5):277-86.
By means of the lymphocyte transformation test (LTT), using the mitogens phytohemagglutinin (PHA), concanavalin A (ConA), lipopolysaccharide (LPS) E. coli and the antigens tuberculin (PPD) and O-streptolysin, a contribution should be made for the judgment of the functional capacity of the immune system--in particular of the cellular immunity--in uraemia patients with and without dialysis therapy. In 33 patients with different duration of the dialysis (0.5 to 130 months) and 15 retention patients who were not yet treated by means of dialysis the LTT was controlled with stimulant agents mentioned above. In these cases was shown that dialysis patients managed metabolically regularly did not show a significant restriction of the cellular immunity in the LTT (PHA-stimulation over 0.55 transformed cells, con-A-stimulation over 0.37 transformed cells). The not dialysed patients with chronic uraemia showed a distinct diminution of the unspecific T-cell transformation by PHA and ConA, whereas the antigen-induced stimulation (PPD, O-streptolysin) was not disturbed in this case as well. In the two cases the B-cell transformation (on LPS) was not significantly disturbed. There was a good concordance with the clinical findings: scarcely general infects, no shunt infections, relatively many organ losses by rejection after transplantation in the dialysis patients. The not yet dialysed retention patients revealed clinically a higher inclination to an infect. There were no own experiences about the course after transplantation without preceding dialysis. It is discussed in how far also immunological investigations may play a role in the establishment of the optimum management of the dialysis, the moment of the beginning with the dialysis and for the "more individual preparation of the transplantation".
通过淋巴细胞转化试验(LTT),使用促有丝分裂原植物血凝素(PHA)、刀豆球蛋白A(ConA)、大肠杆菌脂多糖(LPS)以及抗原结核菌素(PPD)和O-链球菌溶血素,应当对有或无透析治疗的尿毒症患者免疫系统——尤其是细胞免疫——的功能能力判断有所贡献。对33例透析时长不同(0.5至130个月)的患者以及15例尚未接受透析治疗的潴留患者,用上述刺激剂对LTT进行了监测。在这些病例中发现,代谢管理正常的透析患者在LTT中细胞免疫未见明显受限(PHA刺激下转化细胞超过0.55,ConA刺激下转化细胞超过0.37)。慢性尿毒症未透析患者PHA和ConA诱导的非特异性T细胞转化明显降低,而抗原诱导的刺激(PPD、O-链球菌溶血素)在这种情况下也未受干扰。在这两种情况下,B细胞转化(对LPS)未受到明显干扰。这与临床发现高度一致:透析患者几乎没有全身性感染、没有分流感染、移植后因排斥导致的器官丧失相对较多。尚未透析的潴留患者临床上显示出较高的感染倾向。对于未先行透析的移植后病程尚无自身经验。文中讨论了免疫学检查在确定透析的最佳管理、开始透析的时机以及“更个体化的移植准备”方面可能发挥作用的程度。